Why partner with AstraZeneca?

We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.


Total Revenue


Collaboration Revenue


major or strategically important deals completed in last three years


collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs




manufacturing sites in 16 countries

Nearly $6bn

invested in R&D


of pipeline has a precision medicine approach

For year ending 31 December 2020

Pushing the boundaries of science to deliver life-changing medicines

Inspired by our values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.

Encouraging innovation and inspiring the next generation of start-ups

Veeva ID: Z4-32948
Date of Prep: May 2021